Clinical Trial Update: An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome [Phase 2]

View source ↗

Summary

Open-label extension update for STK-001 in Dravet syndrome within a Phase 2 trial; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• STK-001 (STK-001)

Snippet

Sponsor: Stoke Therapeutics, Inc | Conditions: Dravet Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING